findmyKOL
Clinical trialNCT00797706UnknownPhase 1/PHASE2Interventional

Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

SponsorKringle Pharma Europe ABEnrollment75Chronic Venous Leg Ulcers
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate if the investigational medicinal product CHRONSEAL intended for future treatment of chronic venous leg ulcers is safe and tolerated and if it has an ulcer size reduction effect when administered to individuals suffering from venous leg ulcers.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Hans Olav Høivik, MD

    Medi 3 Innlandet AS, avd Hamar

    Principal Investigator
    clinicaltrials.gov ↗
  • Jan Apelqvist, Assoc. Prof., PhD, MD

    Department of Endocrinology, University Hospital Malmö,

    Study Chair
    clinicaltrials.gov ↗
  • Karin Andersson, MD

    Halland County Council, Department of Dermatology and Infectious diseases, Halmstad, Sweden

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Norway
  • Medi3 Innlandet As, Department Elverum

    Elverum, Norway

  • Hudavdelingen Helse

    Førde, Norway

  • Medi 3 Innlandet As, Department Hamar

    Hamar, Norway

  • Colosseumklinikken

    Oslo, Norway

Sweden
  • Vårdcentralen Alvesta

    Alvesta, Sweden

  • Danderyds Sjukhus Ab

    Danderyd, Sweden

  • Carema Vårdcentral Gubbängen

    Enskede, Sweden

  • Department of Dermatology and Infectious Diseases

    Halmstad, Sweden

  • Husläkarna I Kungsbacka

    Kungsbacka, Sweden

  • Department of Dermatology, Lund University Hospital

    Lund, Sweden

  • Department of Dermatology, University Hospital Mas

    Malmö, Sweden

  • Gamla Stans Vårdcentral

    Stockholm, Sweden

  • Taptogatans Husläkare

    Stockholm, Sweden

  • Department of Dermatology, Norrlands University Hospital

    Umeå, Sweden

  • Department of Medical Sciences, Section of Dermatology and Venereology, Uppsala University Hospital

    Uppsala, Sweden

  • Neptunuskliniken

    Varberg, Sweden

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CHRONSEAL
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2008
Primary completion
31 Mar 2010
Completion
31 Mar 2010
Last update posted
5 Feb 2010
Registered enrollment
75
Registry id
NCT00797706
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.